This blog was originally published by the Dengue Vaccine Initiative.

Every three months, the Dengue Vaccine Initiative (DVI) highlights a “Dengue Champion,” calling attention to that person’s contribution to the dengue vaccine research field and their commitment to the fight against dengue fever. Dr.

by Dr. Giovanini Coelho 

Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate.